Company profile for Proteros

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than ...
Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan.As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of responsibility, who enjoy challenges.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Bunsenstr. 7a D - 82152 Martinsried
Telephone
Telephone
+49 89 7007610
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/07/09/3112576/0/en/Qanatpharma-Zuse-Institute-Berlin-Enamine-and-Proteros-biostructures-Announce-Generative-AI-Driven-Lead-Discovery-Collaboration.html

GLOBENEWSWIRE
09 Jul 2025

https://www.globenewswire.com//news-release/2023/09/06/2738041/0/en/Proteros-biostructures-and-Orion-Pharma-agree-on-a-long-term-multi-target-collaboration-including-the-assembly-of-a-joint-novel-and-unique-HTS-small-molecule-screening-library-with.html

GLOBENEWSWIRE
06 Sep 2023

https://www.globenewswire.com/news-release/2023/01/09/2584847/0/en/Proteros-receives-minority-investment-from-private-equity-firm-Inflexion.html

GLOBENEWSWIRE
09 Jan 2023

https://www.globenewswire.com/news-release/2022/10/25/2540748/0/en/Proteros-and-Adrestia-initiate-multi-target-partnership-to-discover-first-in-class-drugs-for-intractable-genetic-diseases.html

GLOBENEWSWIRE
25 Oct 2022
AstraZeneca expands Proteros cancer drug collab
AstraZeneca expands Proteros cancer drug collab

16 May 2022

// Gabrielle Masson FIERCEBIOTECH

https://www.fiercebiotech.com/cro/astrazeneca-gives-proteros-chance-make-75m-expanded-cancer-drug-deal

Gabrielle Masson FIERCEBIOTECH
16 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty